SCHEMBL2802541

SCHEMBL2802541

COc1ccc(Cn2ncc3c4c(cnc32)CN(C(=O)C(NC(=O)OC(C)(C)C)c2ccccc2)CC4)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 5/20 0.41
ALDH1A1 P00352 4/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 2/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
FNTA P49354 1/20 0.38
FNTB P49356 1/20 0.38
ATM Q13315 1/20 0.37
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
S1PR3 Q99500 1/20 0.36
HCRTR2 O43614 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
ENPP2 Q13822 2/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2802544 1.00 ADORA1 (0.41) ADORA1ALDH1A1MAPTLMNAHSD17B10
SCHEMBL2805078 0.91 ADORA1 (0.44) ADORA1ALDH1A1MAPTLMNAHSD17B10
SCHEMBL12315704 0.90 ADORA1 (0.41) ADORA1ALDH1A1MAPTLMNAHSD17B10
SCHEMBL12315755 0.87 ADORA1 (0.43) ADORA1ALDH1A1MAPTLMNAHSD17B10
SCHEMBL2489943 0.85 ADORA1 (0.46) ADORA1ALDH1A1MAPTLMNAHSD17B10
Trifluoroacetic Acid SCHEMBL2487824 0.84 ADORA1 (0.40) ADORA1ALDH1A1MAPTLMNAHSD17B10
SCHEMBL2802902 0.84 ADORA1 (0.44) ADORA1ALDH1A1MAPTLMNAHSD17B10
SCHEMBL2806919 0.83 ADORA1 (0.40) ADORA1ALDH1A1MAPTLMNAHSD17B10
SCHEMBL2488918 0.83 MAPT (0.51) ALDH1A1MAPTLMNAHSD17B10HPGD
Trifluoroacetic Acid SCHEMBL2486009 0.82 ADORA1 (0.41) ADORA1ALDH1A1MAPTLMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8263610-B2 Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds ARQULE, INC. (US) 2012-09-11 US disclosed
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239526-A1 SUBSTITUTED IMIDAZOLYL-5,6-DIHYDROBENZO[N]ISOQUINOLINE COMPOUNDS NQO1, IDH3B, IDH1 ADORA1 3692/4885ALDH1A1 460/4885MAPT 3332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.